Some 16 years after randomized trials of PSA screening commenced in Europe and the US, many people anticipated that they would provide “the definitive answer” to this thorny issue. Both trials published their preliminary findings in the March 26, 2009 issue of the New England Journal of Medicine, and the results are apparently conflicting. This article helps interpret the studies (the full texts are available on the NEJM website at http://content.nejm.org).
What to expect
by Dr. Peter Black
Earlier diagnosis and new approaches are changing the face of prostate cancer
Prostate cancer is the most common cancer and the third leading cause of cancer death in men in Canada.